Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients

The aim of this study was to explore the role of combined pretreatment serum carbohydrate antigen 19-9 (CA19-9) and neutrophil-to-lymphocyte ratio (NLR) as potential prognostic factors in metastatic pancreatic cancer patients. We investigated pretreatment serum CA19-9 and NLR in 59 metastatic pancre...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jian-Yuan, Chen, Ming-Qiu, Guo, Jing-Hua, Lian, Shi-Feng, Xu, Ben-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794383/
https://www.ncbi.nlm.nih.gov/pubmed/29369199
http://dx.doi.org/10.1097/MD.0000000000009707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794383/
https://www.ncbi.nlm.nih.gov/pubmed/29369199
http://dx.doi.org/10.1097/MD.0000000000009707

Ejemplares similares